Filter Results
:
(1,106)
Show Results For
-
All HBS Web
(1,106)
- People (1)
- News (307)
- Research (682)
- Events (5)
- Multimedia (15)
- Faculty Publications (397)
Show Results For
-
All HBS Web
(1,106)
- People (1)
- News (307)
- Research (682)
- Events (5)
- Multimedia (15)
- Faculty Publications (397)
- February 2019 (Revised September 2019)
- Case
Theranos: The Unicorn That Wasn't
By: Joseph B. Fuller and John Masko
In 2003, 19-year-old Elizabeth Holmes founded a startup dedicated to making blood testing easier and more affordable. By 2015, her company, Theranos, was worth $9 billion. It boasted a star-studded board and contracts with national pharmacy and supermarket chains...
View Details
Keywords:
Theranos;
Blood;
Lab Testing;
Fraud;
Holmes;
Balwani;
Shultz;
Carreyrou;
Securities And Exchange Commission;
Food And Drug Administration;
FDA;
SEC;
Health Testing and Trials;
Corporate Accountability;
Organizational Culture;
Misleading and Fraudulent Advertising;
Crime and Corruption;
Entrepreneurship;
Medical Devices and Supplies Industry
Fuller, Joseph B., and John Masko. "Theranos: The Unicorn That Wasn't." Harvard Business School Case 319-068, February 2019. (Revised September 2019.)
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new...
View Details
Keywords:
Health Care and Treatment;
Laws and Statutes;
Research and Development;
Investment;
Markets;
Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- 2023
- Working Paper
Life After Death: A Field Experiment with Small Businesses on Information Frictions, Stigma, and Bankruptcy
By: Shai Benjamin Bernstein, Emanuele Colonnelli, Mitchell Hoffman and Benjamin Iverson
In a randomized control trial (RCT) with U.S. small businesses, we document that a large share of firms are not well-informed about bankruptcy. Many assume that bankruptcy necessarily entails the death of a business and do not know about Chapter 11 bankruptcy, where...
View Details
Bernstein, Shai Benjamin, Emanuele Colonnelli, Mitchell Hoffman, and Benjamin Iverson. "Life After Death: A Field Experiment with Small Businesses on Information Frictions, Stigma, and Bankruptcy." NBER Working Paper Series, No. 30933, February 2023.
- 14 Nov 2017
- First Look
New Research and Ideas: November 14, 2017
experts to discuss how researchers can impact a broader audience, by lending their scientific expertise to pressing social issues, current events, and public debates. The landmark Brown v. Board of Education case, in which the Supreme...
View Details
Keywords:
Carmen Nobel
- 21 Nov 2013
- News
Case Study: BlackBerry and Thorsten Heins
status quo, and focus on elaborate plans and execution infrastructures, in an environment more suited to trial and error learning. Ultimately,...
View Details
- 2024
- Working Paper
Do Information Frictions and Corruption Perceptions Kill Competition? A Field Experiment on Public Procurement in Uganda
By: Emanuele Colonnelli, Francesco Loiacono, Edwin Muhumuza and Edoardo Teso
We study whether information frictions and corruption perceptions deter firms from doing business with the government. We conduct two nationwide randomized controlled trials (RCTs) in collaboration with the national public procurement supervisory and anti-corruption...
View Details
Keywords:
Knowledge Use and Leverage;
Government and Politics;
Crime and Corruption;
Trust;
Perception;
Business and Government Relations
Colonnelli, Emanuele, Francesco Loiacono, Edwin Muhumuza, and Edoardo Teso. "Do Information Frictions and Corruption Perceptions Kill Competition? A Field Experiment on Public Procurement in Uganda." NBER Working Paper Series, No. 32170, February 2024.
- 12 Jun 2018
- First Look
New Research and Ideas, June 12, 2018
forthcoming Cambridge, MA: Harvard University Press The Academy of Fisticuffs: Political Economy and Commercial Society in Enlightenment Italy By: Reinert, Sophus A. Abstract—The terms “capitalism” and...
View Details
Keywords:
Dina Gerdeman
- 25 Jul 2023
- Research & Ideas
Could a Business Model Help Big Pharma Save Lives and Profit?
Might Also Like: The FDA’s Speedy Drug Approvals Are Safe: A Win-Win for Patients and Pharma Innovation Curbing an Unlikely Culprit of Rising Drug Prices: Pharmaceutical Donations Buy-In from Black Patients Suffers When Drug View Details
- 08 Dec 2003
- Research & Ideas
Why Europe Lags in Pharmaceuticals and Biotech
the preferred testing ground for Phase 1 clinical trials of new drugs, the benefits of massive R&D spending and economic throw-offs are being enjoyed elsewhere, primarily in the United States View Details
- 10 Jul 2018
- First Look
New Research and Ideas, July 10, 2018
business plans, and key personnel ignited a bi-coastal battle between two fierce rivals that was played out in courts competing for jurisdiction and states with diametrically...
View Details
Keywords:
Dina Gerdeman
- Summer 2015
- Article
The Effect of Delaware Doctrine on Freezeout Structure and Outcomes: Evidence on the Unified Approach
By: Fernan Restrepo and Guhan Subramanian
Historically, Delaware corporate law provided different standards of judicial review for buyouts by controlling shareholders (also known as "freezeouts") based on what transactional form was used: deferential business judgment review for freezeouts executed as tender...
View Details
Restrepo, Fernan, and Guhan Subramanian. "The Effect of Delaware Doctrine on Freezeout Structure and Outcomes: Evidence on the Unified Approach." Harvard Business Law Review 5, no. 2 (Summer 2015): 205–236.
- March 2019
- Case
DayTwo: Going to Market with Gut Microbiome
By: Ayelet Israeli and David Lane
DayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals. After a first year of trial rollout in...
View Details
Keywords:
Start-up Growth;
Startup;
Positioning;
Targeting;
Go To Market Strategy;
B2B2C;
B2B Vs. B2C;
Health & Wellness;
AI;
Machine Learning;
Female Ceo;
Female Protagonist;
Science-based;
Science And Technology Studies;
Ecommerce;
Applications;
DTC;
Direct To Consumer Marketing;
US Health Care;
"USA,";
Innovation;
Pricing;
Business Growth;
Segmentation;
Distribution Channels;
Growth and Development Strategy;
Business Startups;
Science-Based Business;
Health;
Innovation and Invention;
Marketing;
Information Technology;
Business Growth and Maturation;
E-commerce;
Applications and Software;
Food and Beverage Industry;
Food and Beverage Industry;
Food and Beverage Industry;
Food and Beverage Industry;
Food and Beverage Industry;
Israel;
United States
Israeli, Ayelet, and David Lane. "DayTwo: Going to Market with Gut Microbiome." Harvard Business School Case 519-010, March 2019.
- 31 Aug 2021
- Book
Feeling Powerless at Work? Time to Agitate, Innovate, and Orchestrate
shantytowns. But in an effort to grow her organization and help more people, she eventually began courting private donors, public authorities, and the general public. By 2016,...
View Details
Keywords:
by Jay Fitzgerald
- 14 May 2020
- News
Perspectives in Health: Everlywell, Diagnostics and COVID
- 08 Mar 2019
- Research & Ideas
Seven Negotiation Lessons from Amazon's HQ Disaster in Queens
negotiating too narrowly with those who have formal power and authority. Negotiation experts have a patriarchal name for a version of this classic—and avoidable—mistake: Decide-Announce-Defend or DAD. Along with gaining the full-throated...
View Details
- 18 Dec 2018
- First Look
New Research and Ideas, December 18, 2018
firms face little competition, even after the end of formal periods of patent protection and market exclusivity. Additionally, the evolving technologies of drug development—in particular, the increasingly common use of auxiliary endpoints...
View Details
Keywords:
Dina Gerdeman
- September 1984 (Revised July 2005)
- Case
Higgins v. Commissioner
By: Henry B. Reiling
Discusses the issue of whether an activity is a trade or business. The Court held that the taxpayer's very substantial stock and bond portfolio management activities were not a trade or business, whereas the taxpayer's real estate activities did constitute a trade or...
View Details
Reiling, Henry B. "Higgins v. Commissioner." Harvard Business School Case 285-008, September 1984. (Revised July 2005.)
- March 1991 (Revised July 2001)
- Supplement
Ann Hopkins (B)
By: Joseph L. Badaracco Jr. and Ilyse Barkan
Describes the reasons why the courts found in favor of Ann Hopkins in the sexual discrimination suit. Also explains why the courts concluded she was the victim of sexual stereotyping.
View Details
Badaracco, Joseph L., Jr., and Ilyse Barkan. "Ann Hopkins (B)." Harvard Business School Supplement 391-170, March 1991. (Revised July 2001.)
- 01 Dec 2020
- News
New Releases: Alumni and Faculty Books
you could learn from rejection. In Spring, he puts a gentle arm around your shoulders and helps you bounce back stronger than ever from every rejection. Juror Number Two By Efrem Sigel (MBA 1968) The Writers Press This riveting memoir...
View Details
Keywords:
Margie Kelley
- 22 Feb 2022
- News
March 2022 Alumni and Faculty Books
bloc or the programs that Soviets, East Germans, Cubans, Chinese, and other outsiders tried to promote. Instead, they attempted to forge new models of socialist development through their own trial View Details